Intracameral Dexamethasone Injection as Adjuvant Therapy in Endothelial Immune Reaction After Penetrating and Posterior Lamellar Keratoplasty: A Retrospective Clinical Observation

Intracameral Dexamethasone Injection as Adjuvant Therapy in Endothelial Immune Reaction After... Adv Ther (2017) 34:1928–1935 DOI 10.1007/s12325-017-0583-y ORIGINAL RESEARCH Intracameral Dexamethasone Injection as Adjuvant Therapy in Endothelial Immune Reaction After Penetrating and Posterior Lamellar Keratoplasty: A Retrospective Clinical Observation . . . Miltiadis Fiorentzis Arne Viestenz Anja Viestenz Berthold Seitz Received: May 28, 2017 / Published online: June 30, 2017 Springer Healthcare Ltd. 2017 after a period of 6 weeks and 3 months. Results ABSTRACT were compared using the Wilcoxon signed-rank test. Introduction: The aim of this observational Results: BCVA of the patients in the study study is to evaluate the effectiveness of an group increased from logMAR 1.5 ± 0.77 at adjuvant intracameral corticosteroid injection baseline to 0.99 ± 0.44 (p = 0.009) at 6 weeks (ICI) in cases of severe endothelial immune and to 0.78 ± 0.45 (p = 0.017) at 3 months fol- reaction (SEIR) (anterior chamber cells and flare, lowing the ICI. The CCT decreased from retrocorneal precipitates, Descemet’s folds, and 835 ± 211 lm at baseline to 609 ± 63 lm corneal edema) after penetrating keratoplasty (p = 0.005) after 3 months. ECC showed a sig- and posterior lamellar keratoplasty. nificant reduction 12 weeks after treatment in Methods: In this retrospective study, 24 sub- both http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Advances in Therapy Springer Journals

Intracameral Dexamethasone Injection as Adjuvant Therapy in Endothelial Immune Reaction After Penetrating and Posterior Lamellar Keratoplasty: A Retrospective Clinical Observation

Loading next page...
 
/lp/springer_journal/intracameral-dexamethasone-injection-as-adjuvant-therapy-in-XQDoN0x0qd
Publisher
Springer Healthcare
Copyright
Copyright © 2017 by Springer Healthcare Ltd.
Subject
Medicine & Public Health; Internal Medicine; Oncology; Cardiology; Rheumatology; Endocrinology; Pharmacology/Toxicology
ISSN
0741-238X
eISSN
1865-8652
D.O.I.
10.1007/s12325-017-0583-y
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial